Short answer
CONMED Corp (CNMD) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 fiscal 2026 results for quarter ended September 30, 2026.
CONMED Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 fiscal 2026 results for quarter ended September 30, 2026
- CONMED issued the earnings announcement on October 28, 2026
- Detailed financial results and management commentary in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q3 sales $335.6M, down 0.7% reported, while organic constant-currency growth reached 6.7% excluding GI exits
- Adjusted diluted EPS $1.04, down 3.2%, but above management expectations, with adjusted EBITDA margin improving to 20.2% from 19.4%
- International sales rose 13.1% reported, offsetting 11.0% domestic decline and highlighting geographic mix dependence
- GAAP diluted EPS increased to $0.66 from $0.09, aided by lower operational charges and portfolio-related items
- Full-year sales guidance narrowed to $1,360M-$1,366M, while adjusted EPS guidance increased to $4.54-$4.61ેણ
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CONMED Corp 8-K filings
Get the next CNMD 8-K as it lands
Follow CNMD for push alerts, or ask the research agent what this filing means.